BioCryst Pharmaceuticals
BCRXBioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. BioCryst's antiviral drug RAPIVAB was approved by FDA in Dec 2014.
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2023-2025
All insider trades at BioCryst Pharmaceuticals
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 12/13/2024 | Sell | Hutson, Nancy J. | Director | $7.5 | $52,780 |
| 6/24/2024 | Sell | Mckee, Amy E. | Director | $6.3 | $54,352 |
| 6/17/2024 | Sell | Sanders, Machelle | Director | $6.0 | $28,134 |
| 6/14/2024 | Sell | Heggie, Theresa | Director | $6.1 | $40,925 |
| 5/30/2024 | Buy | Levin, Alan G. | Director | $6.4 | $49,996 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)